SCHEMBL23397291

SCHEMBL23397291

CCOc1ccc2c(ccn2C(=O)OC(C)C)c1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 2/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.33
▸ HTT P42858 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ TSHR P16473 3/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ ACACB O00763 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ABHD10 Q9NUJ1 1/20 0.32
▸ BRD4 O60885 2/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18054331 0.87 NPSR1 (0.39) HTTLMNAPOLBL3MBTL1TSHR
SCHEMBL18054225 0.86 BCHE (0.34) GPR119HTTLMNAL3MBTL1KMT2A
SCHEMBL20224103 0.82 NOTUM (0.33) BCHE
SCHEMBL18054133 0.82 ELANE (0.34) HTTLMNAPOLBTSHRKDM4E
SCHEMBL20977762 0.81 ACACB (0.36) PTGS2PTGS1GPR119HTTLMNA
SCHEMBL23397289 0.81 ACACB (0.36) PTGS2PTGS1GPR119LMNAPOLB
SCHEMBL18054356 0.78 KDR (0.35) PTGS2PTGS1GPR119HTTLMNA
SCHEMBL18054137 0.77 PTGS2 (0.35) PTGS2PTGS1GPR119HTTLMNA
SCHEMBL18052970 0.76 ALDH1A1 (0.39) LMNAPOLBTSHRKMT2AKDM4E
SCHEMBL20227228 0.76 NOTUM (0.40) BCHEKDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3261637-B1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE INC (US) 2021-05-26 — — EP disclosed
Send feedback